Skip to content

Genetic Basis of Rosacea Study (Control)

Expansion Arm of Papulopustular Rosacea Gene Expression Profiling to Include Normal Individuals as Anatomic Site Specific Controls

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02749786
Enrollment
10
Registered
2016-04-25
Start date
2016-01-21
Completion date
2016-08-01
Last updated
2019-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rosacea

Brief summary

Rosacea is a common disease characterized by inflammation and vascular abnormalities of the facial skin and ocular surface. It it considered to be a syndrome encompassing various combinations of cutaneous signs including flushing, erythema, telangiectasia, papules, edema, ocular lesions, and rhinophyma. The exact etiology of cutaneous rosacea is unknown but is characterized by persistent vasodilation, increased vascular permeability, and vascular hyper-reactivity of the microcirculation of the central part of the face. The purpose of this study is to develop gene expression profiles of papulopustular rosacea compared to those of normal skin. The investigator hopes to better understand the abnormal gene functions that might contribute to this condition. This understanding may lead to the development of additional and better treatments for rosacea.

Interventions

OTHERSkin Biopsy

Skin biopsies will be performed via the Keys punch technique from normal facial skin.

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

include: 1. Fitzpatrick skin type II or III 2. Age greater than or equal to 18 years 3. Individuals without a history of rosacea

Exclusion criteria

include: 1. Women who are pregnant or lactating 2. Use of topical prescription medications or procedures to the face within one month of enrollment 3. Skin conditions that might interfere with interpretation of procedure results (at the discretion of the investigator)

Design outcomes

Primary

MeasureTime frame
Gene expression profile of papulopustular rosacea compared to normal skin and skin from individuals without rosacea.Up to 2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026